Skip to main content

Advertisement

Log in

Low expression of chemokine receptor CCR5 in human colorectal cancer correlates with lymphatic dissemination and reduced CD8+ T-cell infiltration

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Background

Chemokines and their receptors have been proposed to distinctly contribute to tumor growth, dissemination, and local immune escape. The aim of this study was to evaluate the relevance of the chemokine receptor CCR5 expression for the progression of human colorectal cancer.

Methods

CCR5 expression was assessed by RT-PCR analysis in 103 colorectal cancer patients. Intensity of CCR5 expression was correlated with both tumor and patient characteristics. Infiltration of tumor margins with CD8+ T cells in the context of CCR5 expression was analyzed by immunohistochemistry in additional 18 colorectal cancer specimens.

Results

Human colorectal cancer revealed variable intensities of CCR5 expression ranging from absent (48/103: 47%), weak (30/103: 29%), intermediate (13/103: 13%), to strong (12/103: 12%). Absent or weak CCR5 expression was significantly associated with advanced UICC stages (P = 0.02) and lymphatic metastasis (P = 0.05). In addition, CCR5 expression positively correlated with CD8+ T-cell infiltration in tumor margins (P = 0.001).

Conclusion

In summary, intermediate and strong CCR5 expression was significantly associated with nonmetastatic colorectal cancer and increased CD8+ T-cell infiltration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Greenlee RT, Murray T, Bolden S, Wingo PA (2000) Cancer statistics, 2000. CA Cancer J Clin 50(1):7–33

    Article  CAS  PubMed  Google Scholar 

  2. Weir HK, Thun MJ, Hankey BF et al (2003) Annual report to the nation on the status of cancer, 1975–2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 95(17):1276–1299

    PubMed  Google Scholar 

  3. August DA, Ottow RT, Sugarbaker PH (1984) Clinical perspective of human colorectal cancer metastasis. Cancer Metastasis Rev 3(4):303–324

    Article  CAS  PubMed  Google Scholar 

  4. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61(5):759–767

    Article  CAS  PubMed  Google Scholar 

  5. Cho KR, Vogelstein B (1992) Suppressor gene alterations in the colorectal adenoma-carcinoma sequence. J Cell Biochem Suppl 16G:137–141

    Article  CAS  PubMed  Google Scholar 

  6. Vogelstein B, Kinzler KW (1993) The multistep nature of cancer. Trends Genet 9(4):138–141

    Article  CAS  PubMed  Google Scholar 

  7. Smith G, Carey FA, Beattie J et al (2002) Mutations in APC, Kirsten-ras, and p53–alternative genetic pathways to colorectal cancer. Proc Natl Acad Sci U S A 99(14):9433–9438

    Article  CAS  PubMed  Google Scholar 

  8. Jass JR, Love SB, Northover JM (1987) A new prognostic classification of rectal cancer. Lancet 1(8545):1303–1306

    Article  CAS  PubMed  Google Scholar 

  9. Menon AG, Janssen-van Rhijn CM, Morreau H et al (2004) Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis. Lab Invest 84(4):493–501

    Article  CAS  PubMed  Google Scholar 

  10. Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E, Kosma VM (1997) Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol 182(3):318–324

    Article  CAS  PubMed  Google Scholar 

  11. Chiba T, Ohtani H, Mizoi T et al (2004) Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micrometastasis. Br J Cancer 91(9):1711–1717

    CAS  PubMed  Google Scholar 

  12. Naito Y, Saito K, Shiiba K et al (1998) CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 58(16):3491–3494

    CAS  PubMed  Google Scholar 

  13. Ohtani H, Naito Y, Saito K, Nagura H (1997) Expression of costimulatory molecules B7–1 and B7–2 by macrophages along invasive margin of colon cancer: a possible antitumor immunity? Lab Invest 77(3):231–241

    CAS  PubMed  Google Scholar 

  14. Saito K, Takeha S, Shiba K et al (2000) Clinicopathologic significance of urokinase receptor- and MMP-9-positive stromal cells in human colorectal cancer: functional multiplicity of matrix degradation on hematogenous metastasis. Int J Cancer 86(1):24–29

    Article  CAS  PubMed  Google Scholar 

  15. Loetscher M, Gerber B, Loetscher P et al (1996) Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 184(3):963–969

    Article  CAS  PubMed  Google Scholar 

  16. Nakanishi H, Monden T, Morimoto H, Kobayashi T, Shimano T, Mori T (1991) Perforin expression in lymphocytes infiltrated to human colorectal cancer. Br J Cancer 64(2):239–242

    CAS  PubMed  Google Scholar 

  17. Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunity 12(2):121–127

    Article  CAS  PubMed  Google Scholar 

  18. Arya M, Patel HR, Williamson M (2003) Chemokines: key players in cancer. Curr Med Res Opin 19(6):557–564

    Article  CAS  PubMed  Google Scholar 

  19. Muller A, Homey B, Soto H et al (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410(6824):50–56

    Article  CAS  PubMed  Google Scholar 

  20. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357(9255):539–545

    Article  CAS  PubMed  Google Scholar 

  21. Brigati C, Noonan DM, Albini A, Benelli R (2002) Tumors and inflammatory infiltrates: friends or foes? Clin Exp Metastasis 19(3):247–258

    Article  CAS  PubMed  Google Scholar 

  22. Charo IF, Ransohoff RM (2006) The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354(6):610–621

    Article  CAS  PubMed  Google Scholar 

  23. Tan MC, Goedegebuure PS, Belt BA et al (2009) Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer. J Immunol 182(3):1746–1755

    CAS  PubMed  Google Scholar 

  24. Samson M, Labbe O, Mollereau C, Vassart G, Parmentier M (1996) Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry 35(11):3362–3367

    Article  CAS  PubMed  Google Scholar 

  25. Le Y, Zhou Y, Iribarren P, Wang J (2004) Chemokines and chemokine receptors: their manifold roles in homeostasis and disease. Cell Mol Immunol 1(2):95–104

    CAS  PubMed  Google Scholar 

  26. Yoshie O, Imai T, Nomiyama H (2001) Chemokines in immunity. Adv Immunol 78:57–110

    Article  CAS  PubMed  Google Scholar 

  27. Iida N, Nakamoto Y, Baba T et al (2008) Tumor cell apoptosis induces tumor-specific immunity in a CC chemokine receptor 1- and 5-dependent manner in mice. J Leukoc Biol 84(4):1001–1010

    Article  PubMed  Google Scholar 

  28. Musha H, Ohtani H, Mizoi T et al (2005) Selective infiltration of CCR5(+)CXCR3(+) T lymphocytes in human colorectal carcinoma. Int J Cancer 116(6):949–956

    Article  CAS  PubMed  Google Scholar 

  29. Kondo T, Nakazawa H, Ito F et al (2006) Favorable prognosis of renal cell carcinoma with increased expression of chemokines associated with a Th1-type immune response. Cancer Sci 97(8):780–786

    Article  CAS  PubMed  Google Scholar 

  30. Sugasawa H, Ichikura T, Tsujimoto H et al (2008) Prognostic significance of expression of CCL5/RANTES receptors in patients with gastric cancer. J Surg Oncol 97(5):445–450

    Article  PubMed  Google Scholar 

  31. Borczuk AC, Papanikolaou N, Toonkel RL et al (2008) Lung adenocarcinoma invasion in TGFbetaRII-deficient cells is mediated by CCL5/RANTES. Oncogene 27(4):557–564

    Article  CAS  PubMed  Google Scholar 

  32. Schimanski CC, Schwald S, Simiantonaki N et al (2005) Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer. Clin Cancer Res 11(5):1743–1750

    Article  CAS  PubMed  Google Scholar 

  33. Schrader AJ, Lechner O, Templin M et al (2002) CXCR4/CXCL12 expression and signalling in kidney cancer. Br J Cancer 86(8):1250–1256

    Article  CAS  PubMed  Google Scholar 

  34. Kawamata H, Furihata T, Omotehara F et al (2003) Identification of genes differentially expressed in a newly isolated human metastasizing esophageal cancer cell line, T.Tn-AT1, by cDNA microarray. Cancer Sci 94(8):699–706

    Article  CAS  PubMed  Google Scholar 

  35. Sato N, Fukushima N, Maitra A et al (2004) Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas. Am J Pathol 164(3):903–914

    CAS  PubMed  Google Scholar 

  36. Spano JP, Andre F, Morat L et al (2004) Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome. Ann Oncol 15(4):613–617

    Article  PubMed  Google Scholar 

  37. Kwak MK, Hur K, Park DJ et al (2005) Expression of chemokine receptors in human gastric cancer. Tumour Biol 26(2):65–70

    Article  CAS  PubMed  Google Scholar 

  38. Nath A, Chattopadhya S, Chattopadhyay U, Sharma NK (2006) Macrophage inflammatory protein (MIP)1alpha and MIP1beta differentially regulate release of inflammatory cytokines and generation of tumoricidal monocytes in malignancy. Cancer Immunol Immunother 55(12):1534–1541

    Article  CAS  PubMed  Google Scholar 

  39. Liu Y, Poon RT, Feng X, Yu WC, Luk JM, Fan ST (2004) Reduced expression of chemokine receptors on peripheral blood lymphocytes in patients with hepatocellular carcinoma. Am J Gastroenterol 99(6):1111–1121

    Article  CAS  PubMed  Google Scholar 

  40. Manes S, Mira E, Colomer R et al (2003) CCR5 expression influences the progression of human breast cancer in a p53-dependent manner. J Exp Med 198(9):1381–1389

    Article  CAS  PubMed  Google Scholar 

  41. Zlotnik A (2006) Involvement of chemokine receptors in organ-specific metastasis. Contrib Microbiol 13:191–199

    Article  CAS  PubMed  Google Scholar 

  42. Franciszkiewicz K, Le Floc’h A, Jalil A et al (2009) Intratumoral induction of CD103 triggers tumor-specific CTL function and CCR5-dependent T-cell retention. Cancer Res 69(15):6249–6255

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carl C. Schimanski.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zimmermann, T., Moehler, M., Gockel, I. et al. Low expression of chemokine receptor CCR5 in human colorectal cancer correlates with lymphatic dissemination and reduced CD8+ T-cell infiltration. Int J Colorectal Dis 25, 417–424 (2010). https://doi.org/10.1007/s00384-009-0868-y

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-009-0868-y

Keywords

Navigation